Toxicology Services Global Market – Forecast to 2025

Publishing Date : November, 2017
Report Code : HCPH0108
Price:
Single license $4,950
Site license $6,750
Global license $9,000


The study of adverse effects of chemicals and other biologic substances on living organisms is termed as toxicology. The term toxicology is broadly used in various industries such as agrochemical, pharmaceutical, medical devices, cosmetics, and others. Toxicologists are responsible for the development, implementation, and interpretation of toxicological tests to meet regulatory requirements and data quality standards (e.g., GLPs). According to IQ4I analysis, the toxicology services global market is expected to grow at high single digit CAGR to reach $14,343.0 million by 2025. Mandatory toxicology testing in various industries such as pharmaceutical, agriculture, environmental and chemical, rapid technology advancements, increased demand for crop protection are some of the driving factors for this industry. Increasing trend in outsourcing the toxicology services and increasing end stage drug failures are creating newer opportunities for the market to grow. However, opposition to animal testing in case of in vivo tests and increased funding towards drug repurposing are hindering the market to grow.

Toxicology services global market is classified based on methods, industries, endpoint tests, and geography. Based on methods the toxicology services market can be divided into two segments i.e., in vivo, and in vitro. In silico methods have been included in the in vitro segment along with ex vivo methods. Based on industries the segment is further classified as pharmaceutical industry (discovery and preclinical), medical device industry, cosmetics, chemical industry (industrial chemicals, agrochemicals, environmental) and others (consumer goods and food). The endpoints segment can be classified as systemic toxicology, organ toxicology, dermal toxicology, neurotoxicology, ocular toxicology, genotoxicology, developmental and reproductive toxicology, carcinogenicity and ecotoxicology.

Based on geography toxicology services global market is classified as North America, Europe, APAC and Rest of the world. North America accounts for the highest market share followed by Europe. The region is backed by huge government funding, mandatory toxicology testing regulations and streamlined toxicology guidelines which makes the volume of tests higher. Particularly in the case of pharmaceutical industry, the research for new drug candidates in on a rise taking a look at the pipeline drugs which makes these regions grow in terms of revenue and market size. However, Asian countries especially China and India are the fastest growing regions with its growing demand for toxicology services products.

Major players in toxicology services market include Charles River Laboratories (U.S.), Labcorp (Covance) (U.S.), Envigo (U.S.), MPI Research Inc. (U.S.), Eurofins (Luxembourg), Wuxi (China), SGS (Switzerland), Merck KGaA (Bioreliance Inc.) (Germany), Evotec (Germany), Bureau Veritas (Maxxam) (France).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

• North America

o U.S.

o Others

 

• Europe

o Germany

o U.K.

o France

o Others

 

• Asia-Pacific

o Japan

o China

o India

o Others

 

• Rest of the World (RoW)

o Brazil

o Rest of Latin America

o Middle-East and Others

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN AND DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     PRIMARY SOURCES
      • 2.5.5     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     MANDATORY TOXICOLOGY TESTING IN VARIOUS INDUSTRIES & RISE IN GLOBAL R&D INVESTMENTS
        • 3.3.1.2     INCREASING OUTSOURCING TREND
        • 3.3.1.3     INCREASED FUNDING BY THE PUBLIC AND PRIVATE SECTOR
        • 3.3.1.4     CROP PROTECTION DEMAND DRIVEN BY THE ONGOING NEED TO INCREASE THE EFFICIENCY OF FOOD PRODUCTION TO FEED GROWING GLOBAL POPULATIONS
        • 3.3.1.5     RAPID ADVANCES IN TECHNOLOGIES
        • 3.3.1.6     INCREASING PRODUCT FAILURE DUE TO SAFETY CONCERNS
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     HIGH COST AND LONG DURATION OF TESTS
        • 3.3.2.2     HIGH CAPITAL AND TECHNICAL REQUIREMENTS FOR GLP CERTIFICATION
        • 3.3.2.3     INCREASED FUNDING TOWARDS REPURPOSING
        • 3.3.2.4     OPPOSITION TO ANIMAL TESTING
        • 3.3.2.5     LIMITED IP PROTECTION IN DEVELOPING REGIONS
    • 3.4     REGULATORY AFFAIRS
      • 3.4.1     INTRODUCTION
      • 3.4.2     PHARMACEUTICALS
      • 3.4.3     MEDICAL DEVICES
      • 3.4.4     COSMETICS
      • 3.4.5     CHEMICAL
        • 3.4.5.1     INDUSTRIAL CHEMICAL
        • 3.4.5.2     AGROCHEMICAL, ENVIRONMENTAL AND CONSUMER GOODS
      • 3.4.6     FOOD
    • 3.5     MARKET SHARE ANALYSIS
  • 4     TOXICOLOGY SERVICES GLOBAL MARKET, BY METHOD
    • 4.1     INTRODUCTION
    • 4.2     IN VIVO TOXICOLOGY
    • 4.3     IN VITRO TOXICOLOGY
      • 4.3.1     CELLULAR & BIOCHEMICAL
      • 4.3.2     EX VIVO
      • 4.3.3     IN SILICO
  • 5     TOXICOLOGY SERVICES GLOBAL MARKET, BY INDUSTRY
    • 5.1     INTRODUCTION
    • 5.2     PHARMACEUTICAL
      • 5.2.1     DISCOVERY TOXICOLOGY
      • 5.2.2     PRECLINICAL TOXICOLOGY
    • 5.3     MEDICAL DEVICES
    • 5.4     COSMETICS
    • 5.5     CHEMICAL
      • 5.5.1     INDUSTRIAL CHEMICALS
      • 5.5.2     AGROCHEMICALS
      • 5.5.3     EVIRONMENTAL
    • 5.6     OTHER INDUSTRIES
      • 5.6.1     FOOD
      • 5.6.2     CONSUMER GOODS
  • 6     TOXICOLOGY SERVICES GLOBAL MARKET, BY ENDPOINT TESTS
    • 6.1     INTRODUCTION
    • 6.2     SYSTEMIC TOXICOLOGY
    • 6.3     ORGAN TOXICOLOGY
    • 6.4     DERMAL TOXICOLOGY
    • 6.5     NEUROTOXICOLOGY
    • 6.6     OCULAR TOXICOLOGY
    • 6.7     GENOTOXICOLOGY
    • 6.8     DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
    • 6.9     CARCINOGENICITY
    • 6.1     ECOTOXICOLOGY
  • 7     TOXICOLOGY SERVICES MARKET, BY REGION
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     OTHERS
    • 7.3     EUROPE
      • 7.3.1     GERMANY
      • 7.3.2     FRANCE
      • 7.3.3     U.K.
      • 7.3.4     OTHERS
    • 7.4     ASIA-PACIFIC
      • 7.4.1     CHINA
      • 7.4.2     INDIA
      • 7.4.3     JAPAN
      • 7.4.4     OTHERS
    • 7.5     ROW
      • 7.5.1     BRAZIL
      • 7.5.2     REST OF LATIN AMERICA
      • 7.5.3     MIDDLE EAST & OTHERS
  • 8     COMPANY DEVELOPMENTS
    • 8.1     INTRODUCTION
    • 8.2     ACQUISITIONS & MERGERS
    • 8.3     AGREEMENTS & PARTNERSHIPS
    • 8.4     NEW SERVICE LAUNCH
    • 8.5     OTHERS
  • 9     MAJOR COMPANIES
    • 9.1     BUREAU VERITAS
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     SERVICE PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     CHARLES RIVER LABORATORIES
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     SERVICE PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     EUROFINS SCIENTIFIC
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     SERVICE PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     ENVIGO
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     SERVICE PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     EVOTEC A.G.
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     SERVICE PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     LABORATORY CORP. OF AMERICA HOLDINGS (LABCORP)
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     SERVICE PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     MERCK KGAA
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     SERVICE PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     MPI RESEARCH
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     SERVICE PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     SGS GROUP
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     SERVICE PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     WUXI APPTEC
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     SERVICE PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 2     COMPARISON OF THE TESTS REQUIRED FOR MEDICAL DEVICES APPROVAL BY FDA, ISO AND JAPANEASE MHLW
      • TABLE 3     TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY METHODS (2016-2025) ($MN)
      • TABLE 4     ENDPOINT TESTS FOR IN VIVO TOXICOLOGY
      • TABLE 5     IN VIVO TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 6     IN VITRO GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 7     IN VITRO TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 8     CELLULAR & BIOCHEMICAL TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 9     EX VIVO TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 10     IN SILICO TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 11     TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY INDUSTRY (2016-2025) ($MN)
      • TABLE 12     PHARMACEUTICAL INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 13     MEDICAL DEVICES INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 14     COSMETIC GROUPS/CLASSES
      • TABLE 15     COSMETICS INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 16     CHEMICAL INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 17     CHEMICAL INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 18     INDUSTRIAL CHEMICALS TYPES
      • TABLE 19     INDUSTRIAL CHEMICALS TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 20     TESTS REQUIRED BY THE EPA FOR NEW PESTICIDE CHEMICAL
      • TABLE 21     AGROCHEMICAL TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 22     ENVIRONMENTAL TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 23     OTHER INDUSTRIES TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 24     OTHER INDUSTRIES TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 25     TESTS REQUIRED BY THE EPA FOR NEW PESTICIDE CHEMICAL
      • TABLE 26     FOOD INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 27     CONSUMER GOODS INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 28     COST OF TOXICOLOGY TESTS ($)
      • TABLE 29     TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY ENDPOINT TESTS (2016-2025) ($MN)
      • TABLE 30     SYSTEMIC TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 31     ORGAN TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 32     DERMAL TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 33     NEUROTOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 34     OCCULAR TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 35     GENOTOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 36     DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 37     CARCINOGENICITY TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 38     ECOTOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 39     TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • TABLE 40     NORTH AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2016-2025) ($MN)
      • TABLE 41     NORTH AMERICA IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 42     NORTH AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY INDUSTRY (2016-2025) ($MN)
      • TABLE 43     NORTH AMERICA CHEMICAL INDUSTRY TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 44     NORTH AMERICA OTHER INDUSTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 45     NORTH AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2016-2025) ($MN)
      • TABLE 46     EUROPE TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2016-2025) ($MN)
      • TABLE 47     EUROPE IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2016-2025) ($MN)
      • TABLE 48     EUROPE TOXICOLOGY SERVICES MARKET REVENUE, BY INDUSTRY (2016-2025) ($MN)
      • TABLE 49     EUROPE CHEMICAL INDUSTRY TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 50     EUROPE OTHER INDUSTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 51     EUROPE TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2016-2025) ($MN)
      • TABLE 52     APAC TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2017-2025) ($MN)
      • TABLE 53     APAC IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 54     APAC TOXICOLOGY SERVICES MARKET REVENUE, BY INDUSTRY (2016-2025) ($MN)
      • TABLE 55     APAC CHEMICAL INDUSTRY TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 56     APAC OTHER INDUSTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 57     APAC TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2016-2025) ($MN)
      • TABLE 58     ROW TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2016-2025) ($MN)
      • TABLE 59     ROW IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 60     ROW TOXICOLOGY SERVICES MARKET REVENUE, BY INDUSTRY (2016-2025) ($MN)
      • TABLE 61     ROW CHEMICAL INDUSTRY TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 62     ROW OTHER INDUSTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • TABLE 63     ROW TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2016-2025) ($MN)
      • TABLE 64     ACQUISITIONS & MERGERS (2016-2017)
      • TABLE 65     AGREEMENTS &PARTNERSHIPS (2016-2017)
      • TABLE 66     NEW SERVICE LAUNCH (2016-2017)
      • TABLE 67     OTHERS (2016-2017)
      • TABLE 68     COMPARISON MATRIX FOR TOXICOLOGY SERVICES MARKET PLAYERS, BY INDUSTRY
      • TABLE 69     COMPARISON MATRIX FOR TOXICOLOGY SERVICES MARKET PLAYERS, BY ENDPOINT TESTS
      • TABLE 70     BUREAU VERITAS: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 71     BUREAU VERITAS: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 72     BUREAU VERITAS: TOTAL REVENUE, BY GEOGRAPHY , (2015-2017) ($MN)
      • TABLE 73     CHARLES RIVER LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 74     CHARLES RIVER LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 75     CHARLES RIVER LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 76     EUROFINS SCIENTIFIC: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 77     EUROFINS SCIENTIFIC: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 78     EVOTEC A.G.: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 79     EVOTEC A.G.: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 80     EVOTEC A.G.: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 81     LABCORP: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 82     LABCORP: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 83     MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 84     MERCK KGAA: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 85     MERCK KGAA: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 86     SGS GROUP: TOTAL REVENUE AND R&D EXPENSES, (2015-2017) ($MN)
      • TABLE 87     SGS GROUP: TOTAL REVENUE, BY SEGMENTS, (2015-2017) ($MN)
      • TABLE 88     SGS GROUP: TOTAL REVENUE, BY GEOGRAPHY, (2015-2017) ($MN)
      • TABLE 89     WUXI APPTEC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)

      LIST OF FIGURES

      • FIGURE 1     TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • FIGURE 2     RESEARCH METHODOLOGY: TOXICOLOGY SERVICES GLOBAL MARKET
      • FIGURE 3     TOXICOLOGY SERVICES GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     TOXICOLOGY SERVICES GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     TOXICOLOGY SERVICES: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     TOXICOLOGY SERVICES GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     TOXICOLOGY SERVICES GLOBAL MARKET SHARE ANALYSIS, BY MAJOR PLAYERS, 2017
      • FIGURE 9     TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY METHODS (2016-2025) ($MN)
      • FIGURE 10     IN VIVO TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 11     IN VITRO TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 12     IN VITRO TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • FIGURE 13     CELLULAR & BIOCHEMICAL TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2017) ($MN)
      • FIGURE 14     EX VIVO TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2017) ($MN)
      • FIGURE 15     EX VIVO TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2017) ($MN)
      • FIGURE 16     TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY INDUSTRY (2017) (%)
      • FIGURE 17     PHARMACEUTICAL INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 18     PHARMACEUTICAL INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY ENDPOINT TESTS (2017) (%)
      • FIGURE 19     MEDICAL DEVICES INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 20     MEDICAL DEVICES INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY ENDPOINT TEST (2017) (%)
      • FIGURE 21     COSMETICS INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 22     COSMETICS INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY ENDPOINT TESTS (2017) (%)
      • FIGURE 23     CHEMICAL INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 24     CHEMICAL INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY ENDPOINT TESTS (2017) (%)
      • FIGURE 25     CHEMICAL INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY TYPE (2017) (%)
      • FIGURE 26     INDUSTRIAL CHEMICAL TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 27     AGROCHEMICAL TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 28     ENVIRONMENTAL TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 29     OTHER INDUSTRIES TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 30     OTHER INDUSTRIES TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY ENDPOINT TESTS (2017) (%)
      • FIGURE 31     OTHER INDUSTRIES TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY TYPE (2017) (%)
      • FIGURE 32     FOOD INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 33     CONSUMER GOODS INDUSTRY TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 34     TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY ENDPOINT TESTS (2017) (%)
      • FIGURE 35     SYSTEMIC TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 36     ORGAN TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 37     DERMAL TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 38     NEUROTOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 39     OCCULAR TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 40     GENOTOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 41     DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 42     CARCINOGENICITY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 43     ECOTOXICOLOGY SERVICES GLOBAL MARKET SHARE, BY REGION (2017) (%)
      • FIGURE 44     TOXICOLOGY SERVICES GLOBAL MARKET REVENUE, BY REGION (2016-2025) ($MN)
      • FIGURE 45     NORTH AMERICA TOXICOLOGY SERVICES MARKET SHARE, BY METHODS (2017 VS 2025) (%)
      • FIGURE 46     NORTH AMERICA IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • FIGURE 47     NORTH AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 48     NORTH AMERICA CHEMICAL INDUSTRY TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • FIGURE 49     NORTH AMERICA OTHER INDUSTRIES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • FIGURE 50     NORTH AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 51     U.S. TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS, (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 52     U.S. TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINT TESTS (2017 VS 2025) ($MN)
      • FIGURE 53     OTHER NORTH AMERICA COUNTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS, (2017 VS 2025) ($MN), BY INDUSTRY(2017 VS 2025) ($MN)
      • FIGURE 54     OTHERS TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS, (2017 VS 2025) ($MN)
      • FIGURE 55     EUROPE TOXICOLOGY SERVICES MARKET SHARE, BY METHODS (2017 VS 2025) (%)
      • FIGURE 56     EUROPE IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2016-2025) ($MN)
      • FIGURE 57     EUROPE TOXICOLOGY SERVICES MARKET REVENUE, BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 58     EUROPE CHEMICAL INDUSTRY TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • FIGURE 59     EUROPE OTHER INDUSTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • FIGURE 60     EUROPE TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 61     GERMANY TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS, (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 62     GERMANY TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS, (2017 VS 2025) ($MN)
      • FIGURE 63     FRANCE TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS, (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 64     FRANCE TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 65     U.K. TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 66     U.K. TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 67     OTHER EUROPEAN COUNTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS, (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 68     OTHER EUROPEAN COUNTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 69     APAC TOXICOLOGY SERVICES MARKET SHARE, BY METHODS (2017 VS 2025) (%)
      • FIGURE 70     APAC IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2016-2025) ($MN)
      • FIGURE 71     APAC TOXICOLOGY SERVICES MARKET REVENUE, BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 72     APAC CHEMICAL INDUSTRY TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2017 VS 2025) ($MN)
      • FIGURE 73     APAC OTHER INDUSTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2017 VS 2025) ($MN)
      • FIGURE 74     APAC TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 75     CHINA TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 76     CHINA TOXICOLOGY SERVICES MARKET REVENUE, BY ENDUSERS (2017 VS 2025) ($MN)
      • FIGURE 77     INDIA TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 78     INDIA TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 79     JAPAN TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 80     JAPAN TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 81     APAC OTHER COUNTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 82     APAC OTHER COUNTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 83     ROW TOXICOLOGY SERVICES MARKET SHARE, BY METHODS (2017 VS 2025) (%)
      • FIGURE 84     ROW IN VITRO TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2016-2025) ($MN)
      • FIGURE 85     ROW TOXICOLOGY SERVICES MARKET REVENUE, BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 86     ROW CHEMICAL TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2017 VS 2025) ($MN)
      • FIGURE 87     ROW OTHER INDUSTRIES TOXICOLOGY SERVICES MARKET REVENUE, BY TYPE (2017 VS 2025) ($MN)
      • FIGURE 88     ROW TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 89     BRAZIL TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 90     BRAZIL TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 91     REST OF LATIN AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS, (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 92     REST OF LATIN AMERICA TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 93     MIDDLE EAST & OTHERS TOXICOLOGY SERVICES MARKET REVENUE, BY METHODS, (2017 VS 2025) ($MN), BY INDUSTRY (2017 VS 2025) ($MN)
      • FIGURE 94     MIDDLE EAST & OTHERS TOXICOLOGY SERVICES MARKET REVENUE, BY ENDPOINTS (2017 VS 2025) ($MN)
      • FIGURE 95     KEY GROWTH STRATEGIES (2016-2017)
      • FIGURE 96     SWOT: BUREAU VERITAS
      • FIGURE 97     OVERVIEW: CHARLES RIVER LABORATORIES
      • FIGURE 98     SWOT: CHARLES RIVER LABORATORIES
      • FIGURE 99     OVERVIEW: EUROFINS SCIENTIFIC
      • FIGURE 100     SWOT: EUROFINS SCIENTIFIC
      • FIGURE 101     SWOT: ENVIGO
      • FIGURE 102     OVERVIEW: EVOTEC A.G.
      • FIGURE 103     SWOT: EVOTEC A.G.
      • FIGURE 104     OVERVIEW: LABCORP
      • FIGURE 105     SWOT: LABCORP
      • FIGURE 106     OVERVIEW: MERCK KGAA
      • FIGURE 107     SWOT: MERCK KGAA
      • FIGURE 108     SWOT: MPI RESEARCH
      • FIGURE 109     OVERVIEW: SGS GROUP
      • FIGURE 110     SWOT: SGS GROUP
      • FIGURE 111     SWOT: WUXI APPTEC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ABSORPTION SYSTEMS L.P
      • 2     ACCELERA S.R.L
      • 3     ADMESCOPE
      • 4     ALBANY MOLECULAR RESEARCH, INC. (AMRI)
      • 5     ALS GROUP
      • 6     ALTOGEN LABS
      • 7     AMERICAN PRECLINICAL SERVICES
      • 8     AMPLIA PHARMATEK INC.
      • 9     ANTHEM BIOSCIENCES
      • 10     APT TESTING & RESEARCH PVT. LTD. (ATR)
      • 11     AQUATOX TESTING & CONSULTING INC
      • 12     ATHENA DISCOVERY, INC
      • 13     AURIGENE
      • 14     BATTELLE MEMORIAL INSTITUTE
      • 15     BIENTA/ENAMINE LTD.
      • 16     BIOMED PRECLINICAL SOLUTIONS
      • 17     BIONEEDS INDIA PVT LTD
      • 18     BOLDER BIOPATH, INC.
      • 19     BOZO RESEARCH CENTER
      • 20     BTS RESEARCH
      • 21     BUREAU VERITAS (MAXXAM)
      • 22     BURLESON RESEARCH TECHNOLOGIES, INC.
      • 23     CARE RESEARCH, LLC
      • 24     CENTRE FOR TOXICOLOGY AND ENVIRONMENTAL HEALTH (CTEH )
      • 25     CHARLES RIVER LABORATORIES
      • 26     CHEMDIV, INC.
      • 27     CHEMEX ENVIRONMENTAL INTERNATIONAL LTD
      • 28     CHEMON INC.
      • 29     CHEMPARTNER
      • 30     CIDP
      • 31     CITOX LAB
      • 32     CMIC INC.
      • 33     CNBE INRS
      • 34     COGNIBRAIN
      • 35     COMPARATIVE BIOSCIENCES, INC.
      • 36     COMPUTATIONAL TOXICOLOGY SERVICES LLC
      • 37     CONCEPT LIFE SCIENCES
      • 38     CONCORD BIOSCIENCES LLC
      • 39     CONSUMER PRODUCT TESTING COMPANY
      • 40     CREAGEN BIOSCIENCES INC.
      • 41     CREATIVE ANIMODEL
      • 42     CREATIVE DYNAMICS INC. (CREATIVE BIOARRAY)
      • 43     CROWN BIOSCIENCE INC.
      • 44     CXR BIOSCIENCES
      • 45     DILISYM SERVICES INC
      • 46     DSK INNOSCIENCES
      • 47     EAG LABORATORIES
      • 48     ECOTOX SERVICES INTERNATIONAL
      • 49     EMULATE INC
      • 50     ENVIGO
      • 51     ENVIRONMENTAL BIO-DETECTION PRODUCTS (EBPI)
      • 52     EUROFINS
      • 53     EVOTEC (CYPROTEX PLC., APTUIT)
      • 54     EXELGEN DISCOVERY
      • 55     EXOVA
      • 56     EXPERIMUR
      • 57     EXPLORA BIOLABS
      • 58     FERA SCIENCE LTD.
      • 59     FORMEX LLC (BIODURO)
      • 60     FORTHTOX LTD
      • 61     FRANUHOFER ITEM
      • 62     GATEWAY PHARMACOLOGY LABORATORIES
      • 63     GENEVA LABORATORIES, INC.
      • 64     GLR LABS PVT LTD
      • 65     GREINER BIO-ONE INTERNATIONAL GMBH
      • 66     GVK BIO
      • 67     HEMOGENIX
      • 68     IDSC, LLC.
      • 69     IN SILICO TOXICOLOGY GMBH
      • 70     INA RESEARCH
      • 71     INNOVATIVE ENVIRONMENTAL SERVICES (IES) LTD
      • 72     INSPHERO A.G.
      • 73     INSTITUTE OF INDUSTRIAL ORGANIC CHEMISTRY
      • 74     INTELLISYN RD
      • 75     INTOX PVT. LTD.
      • 76     INVITEK INC.
      • 77     INVITROCUE
      • 78     ITR LABORATORIES CANADA INC.
      • 79     IUVO BIOSCIENCE
      • 80     JAI RESEARCH FOUNDATION
      • 81     JUBILANT BIOSYS
      • 82     KALY-CELL
      • 83     KEMXTREE LLC
      • 84     KRISH BIOTECH
      • 85     LABCORP (COVANCE)
      • 86     LEVEL BIOTECHNOLOGY
      • 87     LOVELACE RESPIRATORY RESEARCH INSTITUTE
      • 88     LPT LABORATORY OF PHARMACOLOGY
      • 89     MB RESEARCH LABORATORIES
      • 90     MERCK KGAA (BIORELIANCE, INC.)
      • 91     MÉRIEUX NUTRISCIENCES CORPORATION
      • 92     METRION BIOSCIENCES
      • 93     MICROCHEM LABORATORY INC
      • 94     MPI RESEARCH INC
      • 95     MURIGENICS
      • 96     NAMSA INC
      • 97     NAUTILUS ENVIRONMENTAL
      • 98     NEO BIOMED SERVICES LTD
      • 99     NOBLE LIFE SCIENCES
      • 100     NOVAMASS LTD
      • 101     NUCROTECHNICS
      • 102     NUMERATE, INC.
      • 103     PACIFIC BIOLABS
      • 104     PACIFIC ECORISK, INC.
      • 105     PARAZA PHARMA, INC.
      • 106     PBR LABORATORIES
      • 107     PHARMACELSUS GMBH
      • 108     PHARMADIRECTIONS INC
      • 109     PHARMALEGACY LABORATORIES
      • 110     PHARMARON, INC.
      • 111     PHARMASEED
      • 112     POLLUTECH GROUP OF COMPANIES INC.
      • 113     PPD
      • 114     PRADO PVT. LTD.
      • 115     PRODUCT SAFETY LABS INC
      • 116     QINGDAO TAIHONGDA CHEMICAL CO.,LTD (FORMERLY PHARMATHD)
      • 117     QPS
      • 118     RCC LABORATORIES INDIA PRIVATE LIMITED
      • 119     ROBIN GUY CONSULTING, LLC
      • 120     ROVALTAIN RESEARCH COMPANY
      • 121     SA-FORD
      • 122     SAI LIFE SCIENCES
      • 123     SBH SCIENCES
      • 124     SELCIA
      • 125     SELVITA SA
      • 126     SEQUANI LTD
      • 127     SGR ESPECIALIZADA
      • 128     SGS
      • 129     SHANGHAI MEDICILON
      • 130     SHIN NIPPON BIOMEDICAL LABORATORIES LTD. (SNBL)
      • 131     SIGNATURE DISCOVER
      • 132     SIMULATIONS PLUS, INC.
      • 133     SINCLAIR RESEARCH
      • 134     SMITHERS VISCIENT
      • 135     SOBRAN
      • 136     SRI INTERNATIONAL
      • 137     SUNDIA MEDITECH CO
      • 138     SYNGENE INTERNATIONAL
      • 139     SYNTECH RESEARCH INC
      • 140     TCG LIFESCIENCES
      • 141     TNO TRISKELION B.V.
      • 142     TOXICOLOGY SOLUTIONS
      • 143     TOXIKON CORPORATION
      • 144     TOXINDIA
      • 145     TOXSTRATEGIES INC.
      • 146     TRE ENVIRONMENTAL STRATEGIES, LLC
      • 147     TUV SUD AG
      • 148     VANTA BIOSCIENCES
      • 149     VIMTA LABS LIMITED
      • 150     VIROCLINICS BIOSCIENCES
      • 151     VIVO BIOTECH LTD
      • 152     VIVO SCIENCE
      • 153     VIVOPHARM PTY LTD
      • 154     VIVOTECNIA
      • 155     WICKHAM LABORATORIES LTD
      • 156     WUXI PHARMATECH
      • 157     XENOMETRICS LLC